Related Experiment Video
Updated: Mar 22, 2026

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
[Progress in epigenetic research on Alzheimer disease]
Nannan Yang1, Yang Wei, Qian Xu
1Department of Neurology, Xiangya Hospital Affiliated to Central South University Xiangya Medical School, Changsha, Hunan 410008, China. bstang7398@163.com.
Epigenetics may play a role in Alzheimer's disease (AD) pathogenesis, influencing factors like aging and environment. This review explores epigenetic mechanisms linked to AD development and progression.
Area of Science:
- Neuroscience
- Genetics
- Pathology
Context:
- Alzheimer's disease (AD) is a leading cause of neurodegeneration, characterized by cognitive decline and memory loss.
- Key pathological hallmarks include amyloid plaques and neurofibrillary tangles.
- The precise causes of AD remain elusive, with aging, genetics, and environmental factors implicated.
Purpose:
- To review current research on epigenetic mechanisms involved in Alzheimer's disease pathogenesis.
- To elucidate how epigenetic modifications influence AD-related factors such as aging and environmental exposures.
Summary:
- Epigenetics offers a potential link between modifiable factors (aging, environment) and Alzheimer's disease.
- This review consolidates advances in understanding epigenetic regulation in AD.
- Focuses on how epigenetic changes contribute to the disease's development.
Impact:
- Highlights the significance of epigenetics in understanding Alzheimer's disease.
- Suggests potential avenues for future research and therapeutic strategies targeting epigenetic pathways.
- Provides a comprehensive overview for researchers in neuroscience and related fields.
More Related Videos
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
04:22Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment